
浏览全部资源
扫码关注微信
1.武警重庆总队医院内分泌科,重庆 400061
2.重庆市渝北区人民医院内分泌科,重庆 401120
董晓颖,Email:dxy079@126.com,研究方向:内分泌及代谢病相关研究。
廖 涌,Email:liaoyong00133@sina.com。
收稿:2025-01-25,
修回:2025-02-12,
录用:2025-02-19,
纸质出版:2025-05-28
移动端阅览
董晓颖,尹经霞,李令,等.美国糖尿病协会2025版糖尿病诊疗标准更新要点解读[J].重庆医科大学学报,2025,50(5):565-573.
Dong Xiaoying,Yin Jingxia,Li Ling,et al.Interpretation of updated key points in the American Diabetes Association’s 2025 Standards of Care in Diabetes[J].Journal of Chongqing Medical University,2025,50(5):565-573.
董晓颖,尹经霞,李令,等.美国糖尿病协会2025版糖尿病诊疗标准更新要点解读[J].重庆医科大学学报,2025,50(5):565-573. DOI: 10.13406/j.cnki.cyxb.003750.
Dong Xiaoying,Yin Jingxia,Li Ling,et al.Interpretation of updated key points in the American Diabetes Association’s 2025 Standards of Care in Diabetes[J].Journal of Chongqing Medical University,2025,50(5):565-573. DOI: 10.13406/j.cnki.cyxb.003750.
美国糖尿病协会(American Diabetes Association,ADA)多年来积极致力于糖尿病诊疗及日常照护标准的制定与推广,自1989年以来每年更新一版糖尿病诊疗标准,已成为糖尿病领域最权威的指南之一,得到了各国的认可和采纳。2024年12月10日,2025版糖尿病诊疗标准发布,融合了与糖尿病及其并发症和合并症相关的最新循证医学证据,旨在为临床医师、患者及家属、研究人员等提供其诊断、治疗、管理方面的指导意见。本文将择其重要更新要点进行解读。
Over the years,the American Diabetes Association(ADA) has been actively committed to the development and promotion of standards for the diagnosis,treatment,and daily care of diabetes. Since 1989,it has updated the diabetes diagnosis and treatment standards every year,which have become one of the most authoritative guidelines in diabetes and have been recognized and adopted by various countries. On December 10,2024,the 2025 Standards of Care in Diabetes were released,incorporating the latest evidence-based medicine content related to diabetes and its complications and comorbidities. It aims to provide guidance on the diagnosis,treatment,and management of the condition for clinicians,patients and their families,and researchers. This article interprets the major updates from the Standards.
Sacks DB , Arnold M , Bakris GL , et al . Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus [J ] . Clin Chem , 2023 , 69 ( 8 ): 808 - 868 .
Eckhardt BJ , Holzman RS , Kwan CK , et al . Glycated hemoglobin a(1c) as screening for diabetes mellitus in HIV-infected individuals [J ] . AIDS Patient Care STDS , 2012 , 26 ( 4 ): 197 - 201 .
Kim PS , Woods C , Georgoff P , et al . A1C underestimates glycemia in HIV infection [J ] . Diabetes Care , 2009 , 32 ( 9 ): 1591 - 1593 .
Holt RIG , DeVries JH , Hess-Fischl A , et al . The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association(ADA) and the European Association for the Study of Diabetes(EASD) [J ] . Diabetologia , 2021 , 64 ( 12 ): 2609 - 2652 .
Khader YS , Dauod AS , El-Qaderi SS , et al . Periodontal status of diabetics compared with nondiabetics:a meta-analysis [J ] . J Diabetes Complications , 2006 , 20 ( 1 ): 59 - 68 .
Casanova L , Hughes FJ , Preshaw PM . Diabetes and periodontal disease:a two-way relationship [J ] . Br Dent J , 2014 , 217 ( 8 ): 433 - 437 .
Eke PI , Thornton-Evans GO , Wei L , et al . Periodontitis in US adults:national health and nutrition examination survey 2009-2014 [J ] . J Am Dent Assoc , 2018 , 149 ( 7 ): 576 - 588 .
Kouidrat Y , Pizzol D , Cosco T , et al . High prevalence of erectile dysfunction in diabetes:a systematic review and meta-analysis of 145 studies [J ] . Diabet Med , 2017 , 34 ( 9 ): 1185 - 1192 .
Broos B , Charleer S , Bolsens N , et al . Diabetes knowledge and metabolic control in type 1 diabetes starting with continuous glucose monitoring:future-PEAK [J ] . J Clin Endocrinol Metab , 2021 , 106 ( 8 ): e3037 - e3048 .
Yoo JH , Kim G , Lee HJ , et al . Effect of structured individualized education on continuous glucose monitoring use in poorly controlled patients with type 1 diabetes:a randomized controlled trial [J ] . Diabetes Res Clin Pract , 2022 , 184 : 109209 .
Rubino F , Batterham RL , Koch M , et al . Lancet diabetes & endocrinology commission on the definition and diagnosis of clinical obesity [J ] . Lancet Diabetes Endocrinol , 2023 , 11 ( 4 ): 226 - 228 .
Klein S , Gastaldelli A , Yki-Järvinen H , et al . Why does obesity cause diabetes? [J ] . Cell Metab , 2022 , 34 ( 1 ): 11 - 20 .
Holt RIG , DeVries JH , Hess-Fischl A , et al . The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association(ADA) and the European Association for the Study of Diabetes(EASD) [J ] . Diabetes Care , 2021 , 44 ( 11 ): 2589 - 2625 .
Mulinacci G , Todd Alonso G , Snell-Bergeon JK , et al . Glycemic outcomes with early initiation of continuous glucose monitoring system in recently diagnosed patients with type 1 diabetes [J ] . Diabetes Technol Ther , 2019 , 21 ( 1 ): 6 - 10 .
Elbalshy M , Haszard J , Smith H , et al . Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus:a systematic review and meta-analysis of randomised controlled trials [J ] . Diabet Med , 2022 , 39 ( 8 ): e14854 .
Champakanath A , Akturk HK , Alonso GT , et al . Continuous glucose monitoring initiation within first year of type 1 diabetes diagnosis is associated with improved glycemic outcomes:7-year follow-up study [J ] . Diabetes Care , 2022 , 45 ( 3 ): 750 - 753 .
Weinstock RS , Xing DY , Maahs DM , et al . Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes:results from the T1D Exchange clinic registry [J ] . J Clin Endocrinol Metab , 2013 , 98 ( 8 ): 3411 - 3419 .
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group , Tamborlane WV , Beck RW , et al . Continuous glucose monitoring and intensive treatment of type 1 diabetes [J ] . N Engl J Med , 2008 , 359 ( 14 ): 1464 - 1476 .
Polonsky WH , Hessler D , Ruedy KJ , et al . The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes:further findings from the DIAMOND randomized clinical trial [J ] . Diabetes Care , 2017 , 40 ( 6 ): 736 - 741 .
Garg SK , Kaur G , Haider Z , et al . Efficacy of semaglutide in overweight and obese patients with type 1 diabetes [J ] . Diabetes Technol Ther , 2024 , 26 ( 3 ): 184 - 189 .
Garg SK , Akturk HK , Kaur G , et al . Efficacy and safety of tirzepatide in overweight and obese adult patients with type 1 diabetes [J ] . Diabetes Technol Ther , 2024 , 26 ( 6 ): 367 - 374 .
Type 1 diabetes impacts of semaglutide on cardiovascular outcomes(T 1 -DISCO) [EB/OL ] .( 2024-11-28 )[ 2025-01-24 ] . https:// clinicaltrials.gov/study/NCT05819138?tab=results https://clinicaltrials.gov/study/NCT05819138?tab=results .
ADJUnct semaglutide treatment in type 1 diabetes(ADJUST-T 1 D) [EB/OL ] .( 2024-08-27 )[ 2025-01-24 ] . https://clinicaltrials.gov/study/NCT05537233 https://clinicaltrials.gov/study/NCT05537233 .
Mills KT , Chen J , Yang W , et al . Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease [J ] . Jama , 2016 , 315 ( 20 ): 2200 .
Whelton PK , Carey RM , Aronow WS , et al . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention,detection,evaluation,and management of high blood pressure in adults:executive summary:a report of the American college of cardiology/American heart association task force on clinical practice guidelines [J ] . Hypertension , 2018 , 71 ( 6 ): 1269 - 1324 .
U.S. Department of Health and Human Services . Physical Activity Guidelines for Americans,2nd edition,2018 [EB/OL ] .( 2024-08-12 )[ 2025-01-24 ] . https://health.gov/sites/default/files/2019-09/Physical_Activity_Guidelines_2nd_ edition.pdf https://health.gov/sites/default/files/2019-09/Physical_Activity_Guidelines_2nd_edition.pdf .
0
浏览量
18
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621